MA44732A - Procédés de production d'arn simple brin - Google Patents

Procédés de production d'arn simple brin

Info

Publication number
MA44732A
MA44732A MA044732A MA44732A MA44732A MA 44732 A MA44732 A MA 44732A MA 044732 A MA044732 A MA 044732A MA 44732 A MA44732 A MA 44732A MA 44732 A MA44732 A MA 44732A
Authority
MA
Morocco
Prior art keywords
single strand
production processes
strand rna
rna production
processes
Prior art date
Application number
MA044732A
Other languages
English (en)
Other versions
MA44732B1 (fr
Inventor
Markus Baiersdörfer
Katalin Karikó
Original Assignee
Biontech Rna Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biontech Rna Pharmaceuticals Gmbh filed Critical Biontech Rna Pharmaceuticals Gmbh
Publication of MA44732A publication Critical patent/MA44732A/fr
Publication of MA44732B1 publication Critical patent/MA44732B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
MA44732A 2016-04-22 2017-04-19 Procédés de production d'arn simple brin MA44732B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2016059056 2016-04-22
PCT/EP2017/059293 WO2017182524A1 (fr) 2016-04-22 2017-04-19 Procédés de production d'arn simple brin

Publications (2)

Publication Number Publication Date
MA44732A true MA44732A (fr) 2021-06-02
MA44732B1 MA44732B1 (fr) 2021-11-30

Family

ID=58699087

Family Applications (1)

Application Number Title Priority Date Filing Date
MA44732A MA44732B1 (fr) 2016-04-22 2017-04-19 Procédés de production d'arn simple brin

Country Status (26)

Country Link
US (1) US20190153425A1 (fr)
EP (2) EP3445850B1 (fr)
JP (2) JP7000343B2 (fr)
KR (2) KR102565881B1 (fr)
CN (1) CN109072232B (fr)
AU (1) AU2017251983B2 (fr)
BR (1) BR112018069417A2 (fr)
CA (1) CA3020481A1 (fr)
CY (1) CY1124845T1 (fr)
DK (1) DK3445850T3 (fr)
ES (1) ES2900272T3 (fr)
HR (1) HRP20211745T1 (fr)
HU (1) HUE059314T2 (fr)
IL (1) IL262304A (fr)
LT (1) LT3445850T (fr)
MA (1) MA44732B1 (fr)
MD (1) MD3445850T2 (fr)
MX (1) MX2018012880A (fr)
PL (1) PL3445850T3 (fr)
PT (1) PT3445850T (fr)
RS (1) RS62612B1 (fr)
RU (2) RU2760790C2 (fr)
SG (2) SG11201807573VA (fr)
SI (1) SI3445850T1 (fr)
WO (1) WO2017182524A1 (fr)
ZA (2) ZA201805949B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3445850B1 (fr) 2016-04-22 2021-10-27 BioNTech SE Procédés de production d'arn simple brin
WO2018188730A1 (fr) * 2017-04-11 2018-10-18 Biontech Rna Pharmaceuticals Gmbh Arn pour le traitement de maladies auto-immunes
WO2019036685A1 (fr) 2017-08-18 2019-02-21 Modernatx, Inc. Procédés pour analyse par clhp
US11926817B2 (en) * 2019-08-09 2024-03-12 Nutcracker Therapeutics, Inc. Microfluidic apparatus and methods of use thereof
EP4103228A1 (fr) 2020-02-13 2022-12-21 Institut Pasteur Vaccin à base d'acide nucléique contre le coronavirus sars-cov-2
WO2021198157A1 (fr) 2020-03-30 2021-10-07 BioNTech SE Compositions d'arn ciblant la claudine-18.2
EP3896161A1 (fr) * 2020-04-17 2021-10-20 Bia Separations D.O.O. Procédé de purification d'arn simple brin
EP3896159A1 (fr) * 2020-04-17 2021-10-20 Bia Separations D.O.O. Procédé de purification d'arn simple brin utilisant un échangeur d'anions
EP3896160A1 (fr) * 2020-04-17 2021-10-20 Bia Separations D.O.O. Procédé de purification d'arn simple brin
WO2021255297A1 (fr) 2020-06-19 2021-12-23 Etherna Immunotherapies Nv Procédé de purification d'arn
TW202237148A (zh) 2020-11-16 2022-10-01 德商拜恩迪克公司 包含rna之lnp組合物以及製備、儲存及使用彼之方法
WO2022218503A1 (fr) 2021-04-12 2022-10-20 BioNTech SE Compositions de npl comprenant de l'arn et procédés de préparation, de stockage et d'utilisation de celles-ci
US20240033344A1 (en) 2020-11-16 2024-02-01 BioNTech SE Pharmaceutical compositions comprising particles and mrna and methods for preparing and storing the same
EP4087938A2 (fr) 2021-01-27 2022-11-16 CureVac AG Procédé de réduction des propriétés immunostimulatrices d'arn transcrit in vitro
CN115197935A (zh) * 2021-04-08 2022-10-18 上海细胞治疗集团有限公司 纤维素色谱纯化rna的方法
CA3215103A1 (fr) 2021-04-12 2022-10-20 Steffen Panzner Compositions d'arn comprenant une substance tampon et procedes de preparation, de stockage et d'utilisation de celles-ci
KR20240006575A (ko) 2021-04-26 2024-01-15 앵스띠뛰 파스퇴르 SARS-CoV-2에 대한 사람 중화 모노클로날 항체 및 이의 용도
EP4355875A1 (fr) * 2021-06-14 2024-04-24 2seventy bio, Inc. Procédés de purification d'arn simple brin
WO2022266389A1 (fr) * 2021-06-17 2022-12-22 Modernatx, Inc. Stratégies alternatives de purification d'arn
CN115505589A (zh) * 2021-07-27 2022-12-23 上海兆维科技发展有限公司 一种rna的制备方法、合成蛋白质的方法以及转录反应液
CA3223943A1 (fr) 2021-07-29 2023-02-02 Ugur Sahin Compositions et methodes de traitement du melanome
WO2023030635A1 (fr) 2021-09-02 2023-03-09 BioNTech SE Test d'activité pour potentiel thérapeutique d'acide nucléique codant
WO2023036960A1 (fr) 2021-09-10 2023-03-16 BioNTech SE Formulations d'arn à base de lipides appropriées pour une thérapie
WO2023051926A1 (fr) 2021-09-30 2023-04-06 BioNTech SE Traitement impliquant un arn non immunogène pour vaccination antigénique et antagonistes liant l'axe pd-1
AU2022374004A1 (en) 2021-10-22 2024-05-02 BioNTech SE Compositions for administration of different doses of rna
WO2023073228A1 (fr) 2021-10-29 2023-05-04 CureVac SE Arn circulaire amélioré pour exprimer des protéines thérapeutiques
CA3236959A1 (fr) * 2021-11-08 2023-05-11 Sue-Jean HONG Compositions d'arn auto-amplifiant et leurs procedes d'utilisation
WO2023083434A1 (fr) 2021-11-09 2023-05-19 BioNTech SE Arn codant pour la peptidoglycane hydrolase et son utilisation pour le traitement d'une infection bactérienne
WO2023126053A1 (fr) 2021-12-28 2023-07-06 BioNTech SE Formulations à base de lipides pour administration d'arn
WO2023147090A1 (fr) 2022-01-27 2023-08-03 BioNTech SE Compositions pharmaceutiques pour administration d'antigènes du virus herpès simplex et méthodes associées
WO2023164258A1 (fr) * 2022-02-28 2023-08-31 Perkinelmer Health Sciences, Inc. Méthodes de séparation et de détection d'acide ribonucléique (arn) double brin et simple brin
WO2023165681A1 (fr) 2022-03-01 2023-09-07 BioNTech SE Nanoparticules lipidiques (npl) d'arn comprenant un polymère de polyoxazoline et/ou de polyoxazine
KR20230142248A (ko) 2022-04-01 2023-10-11 주식회사 엘지에너지솔루션 연성회로기판을 포함하는 파우치형 전지셀
WO2023193892A1 (fr) 2022-04-05 2023-10-12 BioNTech SE Compositions d'acide nucléique comprenant un polyphosphate inorganique et procédés de préparation, de stockage et d'utilisation de celles-ci
WO2023218431A1 (fr) 2022-05-13 2023-11-16 BioNTech SE Compositions d'arn ciblant le vih
CN114921457B (zh) * 2022-05-16 2023-09-29 硅羿科技（上海）有限公司 一种提取dsRNA的方法
WO2023230295A1 (fr) 2022-05-25 2023-11-30 BioNTech SE Compositions d'arn pour l'administration d'antigènes de la variole du singe et méthodes associées
WO2024017479A1 (fr) 2022-07-21 2024-01-25 BioNTech SE Cellules multifonctionnelles exprimant de manière transitoire un récepteur immunitaire et une ou plusieurs cytokines, leur utilisation et leurs procédés de production
WO2024028325A1 (fr) 2022-08-01 2024-02-08 BioNTech SE Compositions d'acide nucléique contenant des composés conjugués-oligo éthylène glycol (oeg) amphiphiles et procédés d'utilisation de tels composés et compositions
WO2024027910A1 (fr) 2022-08-03 2024-02-08 BioNTech SE Arn pour la prévention ou le traitement de la tuberculose
WO2024028445A1 (fr) 2022-08-03 2024-02-08 BioNTech SE Arn pour la prévention ou le traitement de la tuberculose
WO2024063789A1 (fr) 2022-09-23 2024-03-28 BioNTech SE Compositions pour l'administration d'antigènes du paludisme et méthodes associées
WO2024064931A1 (fr) 2022-09-23 2024-03-28 BioNTech SE Compositions pour l'administration d'antigènes du stade hépatique et méthodes associées
WO2024064934A1 (fr) 2022-09-23 2024-03-28 BioNTech SE Compositions pour administration d'antigènes csp de plasmodium et procédés associés
WO2024063788A1 (fr) 2022-09-23 2024-03-28 BioNTech SE Compositions pour l'administration d'antigènes du paludisme et méthodes associées
WO2024074634A1 (fr) 2022-10-06 2024-04-11 BioNTech SE Compositions d'arn ciblant la claudine 18.2
WO2024074211A1 (fr) 2022-10-06 2024-04-11 BioNTech SE Compositions d'arn ciblant la claudine-18.2

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2936240A1 (de) * 1979-09-07 1981-03-26 Bayer Ag, 51373 Leverkusen Verfahren zur herstellung bekannter und neuer 6-amino-6-desoxy-2,3-0-isopropyliden-(alpha)-l-sorbofuranose-derivate sowie neue zwischenprodukte des verfahrens
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US5374548A (en) 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
MX9203291A (es) 1985-06-26 1992-08-01 Liposome Co Inc Metodo para acoplamiento de liposomas.
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
NL8900725A (nl) * 1989-03-23 1990-10-16 Az Univ Amsterdam Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur.
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
ES2336887T5 (es) 2000-03-30 2019-03-06 Whitehead Inst Biomedical Res Mediadores de interferencia por ARN específicos de secuencias de ARN
JP3692395B2 (ja) * 2000-09-01 2005-09-07 独立行政法人農業・生物系特定産業技術研究機構 ベクターモノカリオンを用いた紫紋羽病菌に対するゲノムが２本鎖ｒｎａである糸状菌に寄生するウイルスを導入する新規方法
EP2311994A1 (fr) * 2003-08-01 2011-04-20 Life Technologies Corporation Compositions et procédés de préparation de courtes molécules d'ARN et d'autres acides nucléiques
DE102005046490A1 (de) 2005-09-28 2007-03-29 Johannes-Gutenberg-Universität Mainz Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
CN101086011B (zh) * 2006-06-08 2010-12-08 河南农业大学 食用菌和植物双链rna病毒检测试剂盒及其应用
DE102006061015A1 (de) 2006-12-22 2008-06-26 Curevac Gmbh Verfahren zur Reinigung von RNA im präparativen Maßstab mittels HPLC
PT2167523E (pt) 2007-06-19 2014-09-22 Univ Louisiana State Síntese e utilização de análogos fosforotiolato antireversos do capuz de arn mensageiro
KR102505097B1 (ko) 2009-12-07 2023-03-02 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 세포 리프로그래밍을 위한 정제된 변형 ｒｎａ를 포함하는 ｒｎａ 제제
EP4372081A2 (fr) 2011-12-30 2024-05-22 Cellscript, Llc Fabrication et utilisation d'un arnss synthétisé in vitro à introduire dans des cellules de mammifères pour induire un effet biologique ou biochimique
CN107873055B (zh) * 2015-05-29 2021-09-17 库瑞瓦格房地产有限公司 包括至少一个切向流过滤步骤的产生和纯化rna的方法
EP3445850B1 (fr) 2016-04-22 2021-10-27 BioNTech SE Procédés de production d'arn simple brin

Also Published As

Publication number Publication date
RU2018136601A3 (fr) 2020-09-16
JP7335313B2 (ja) 2023-08-29
CY1124845T1 (el) 2022-11-25
CN109072232B (zh) 2022-11-15
BR112018069417A2 (pt) 2019-01-22
EP4008782A1 (fr) 2022-06-08
MD3445850T2 (ro) 2022-01-31
KR20180135451A (ko) 2018-12-20
LT3445850T (lt) 2021-11-25
JP2022058394A (ja) 2022-04-12
HRP20211745T1 (hr) 2022-02-04
ES2900272T3 (es) 2022-03-16
KR20220041247A (ko) 2022-03-31
JP7000343B2 (ja) 2022-02-10
AU2017251983B2 (en) 2023-07-20
IL262304A (en) 2018-11-29
EP3445850A1 (fr) 2019-02-27
MA44732B1 (fr) 2021-11-30
CN109072232A (zh) 2018-12-21
PL3445850T3 (pl) 2022-01-17
KR102378404B1 (ko) 2022-03-24
SI3445850T1 (sl) 2021-12-31
DK3445850T3 (da) 2021-11-15
ZA201905536B (en) 2023-04-26
MX2018012880A (es) 2019-03-28
PT3445850T (pt) 2021-12-06
HUE059314T2 (hu) 2022-11-28
RU2021134269A (ru) 2022-03-16
AU2017251983A1 (en) 2018-09-27
ZA201805949B (en) 2019-12-18
RS62612B1 (sr) 2021-12-31
RU2018136601A (ru) 2020-05-22
EP3445850B1 (fr) 2021-10-27
CA3020481A1 (fr) 2017-10-26
SG10202010471UA (en) 2020-11-27
SG11201807573VA (en) 2018-10-30
JP2019517782A (ja) 2019-06-27
WO2017182524A1 (fr) 2017-10-26
KR102565881B1 (ko) 2023-08-10
US20190153425A1 (en) 2019-05-23
RU2760790C2 (ru) 2021-11-30

Similar Documents

Publication Publication Date Title
MA44732A (fr) Procédés de production d'arn simple brin
MA47606A (fr) Procédés de purification d'arn messager
MA47605A (fr) Procédés de purification d'arn messager
GB2576227B (en) Animation production system
MA43711A (fr) Procédés de production de l-glufosinate
GB2558335B (en) Novel processes for the production of oligonucleotides
EP3247796A4 (fr) Nanostructructures d'acides nucléiques pourvues de motifs de noyau
MA48798A (fr) Procédé de production d'ozanimod
MA41842A (fr) Nouveaux procédés de sélection d'épitope
MA41298A (fr) Procédés de marquage de banques codées par de l'adn
EP3351594A4 (fr) Toron de résine moulé
EP3314026A4 (fr) Polymorphisme mononucléotidique danshla-b*15:02
ZA201707395B (en) Hatschek process
MA47014A (fr) Procédé de purification d'antibiotiques lipopeptidiques
EP3130597A4 (fr) Oligonucléotide ayant un nucléotide non d'origine naturelle en terminaison 5'
SI3272560T1 (sl) Veriga za pnevmatiko s 45-stopinjskim verižnim nizom
FR3045538B1 (fr) Moto-reducteur d'essuie-glace
GB201609403D0 (en) Booklet production
MA41148A (fr) Procédé de fabrication d'idalopirdine
FR3036295B1 (fr) Accessoire d'aeration de vin
TH183362B (th) "สิ่งเข้มข้นปรุงแต่งรสชาติที่มีรูปร่าง"
GB201522310D0 (en) Novel processes for the production of oligonucleotides
GB201617240D0 (en) Purification process
UA32168S (uk) Формовочний декоративно-рослинний виріб
UA32170S (uk) Формовочний декоративно-рослинний виріб